Vir Biotechnology: Strong Growth Prospects, But Risks Exist … – Seeking Alpha
nopparit/iStock via Getty ImagesYou rarely see a biotechnology firm that becomes profitable in less than ten years of performance. Vir Biotechnology, Inc. (NASDAQ:VIR), a firm with a market cap of $3.35 billion, started on...
AI study finds that patients with Parkinson’s disease speak differently to healthy patients
Using artificial intelligence (AI) to process natural language, a research group evaluated the characteristics of speech among patients with Parkinson’s disease (PD). AI analysis of their data determined that these patients spoke using more...
Organoid Model Allows Study of Microglia in Human-Derived Tissue
An international research team headed by scientists at the Salk Institute for Biological Sciences has developed an organoid model—a three-dimensional collection of cells that mimics features of human tissues—that makes it possible to study...
In a new light – new approach overcomes long-standing limitations in optics
Osaka, Japan – When you look up at the sky and see clouds of wondrous shapes, or struggle to peer through dense, hazy fog, you’re seeing the results of ‘Mie scattering’, which is what...
Novo Nordisk, Flagship’s Metaphore Launch Obesity Collaboration
Imitation is not just the sincerest form of flattery. When combined with machine learning, molecular mimicry is how Metaphore Biotechnologies designs novel treatments in autoimmune disease, oncology—and metabolic disorders, the therapeutic area of its...
Nautilus Biotechnology Reports Second Quarter 2021 Financial Results – GlobeNewswire
SEATTLE, Aug. 10, 2021 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a life sciences company creating a platform technology for quantifying and unlocking the complexity of the proteome, today reported financial...
New radio-labeled molecule may allow a non-invasive approach to monitor inflammation in real time
Researchers at The University of Texas MD Anderson Cancer Center have developed a new radio-labeled molecule capable of selectively reacting with certain high-energy radicals that are characteristic of innate immune activity, which may allow...
New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells – Mirage...
NYU Langone Health / NYU Grossman School of MedicineTargeted therapies specifically attach to and hinder cancer-causing proteins, but cancer cells can quickly evolve to thwart their action. A second drug class, immunotherapies, harnesses the...
BBH: Portfolio Of Large-Cap Biotechnology Stocks Has Delivered Strong Returns – Seeking Alpha
MF3d~ by Snehasish Chaudhuri, MBA (Finance). In my last coverage of VanEck Biotech ETF (NASDAQ:BBH) on April 28th, I noted that BBH: "...will be able to post respectable price growth by the end of...
Institute for the Biotechnology and Medicine Industry inks MoU with hospitals in APAC –...
At the Healthcare+ Expo, held at Nangang Exhibition Center in Taipei, Taiwan, from 1st to 4rth December 2022, the Institute for the Biotechnology and Medicine Industry (IBMI) signed Memorandums of Understanding (MoUs) with hospitals in...
